Safety of concurrent trastuzumab-emtansine and radiation therapy for breast cancer: Single-centre experience from a morbidity and mortality review meetings procedure.

Cancer Radiother

Department of Radiation Oncology and Henri-Mondor Breast Centre, centre hospitalier universitaire Henri-Mondor, 1, rue Gustave-Eiffel, 94000 Créteil, France; Institut Mondor de recherche biomédicale (IMRB), Inserm U955, i-Biot, Upec, Créteil, France.

Published: December 2024

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.canrad.2024.07.019DOI Listing

Publication Analysis

Top Keywords

safety concurrent
4
concurrent trastuzumab-emtansine
4
trastuzumab-emtansine radiation
4
radiation therapy
4
therapy breast
4
breast cancer
4
cancer single-centre
4
single-centre experience
4
experience morbidity
4
morbidity mortality
4

Similar Publications

Strongly coordinating mediator enables single-step resource recovery from heavy metal-organic complexes in wastewater.

Nat Commun

December 2024

State Key Laboratory of Pollution Control and Resource Reuse, Tongji University, Shanghai, 200092, China.

Heavy metals complexed with organic ligands are among the most critical carcinogens threatening global water safety. The challenge of efficiently and cost-effectively removing and recovering these metals has long eluded existing technologies. Here, we show a strategy of coordinating mediator-based electro-reduction (CMBER) for the single-step recovery of heavy metals from wastewater contaminated with heavy metal-organic complexes.

View Article and Find Full Text PDF

Differential effects of fine particulate matter constituents on acute coronary syndrome onset.

Nat Commun

December 2024

School of Public Health, Key Lab of Public Health Safety of the Ministry of Education, Fudan University, Shanghai, China.

Fine particulate matter has been linked with acute coronary syndrome. Nevertheless, the key constituents remain unclear. Here, we conduct a nationwide case-crossover study in China during 2015-2021 to quantify the associations between fine particulate matter constituents (organic matter, black carbon, nitrate, sulfate, and ammonium) and acute coronary syndrome, and to identify the critical contributors.

View Article and Find Full Text PDF

Background: Patients with or at risk for breast cancer may opt for risk-reducing gynecologic surgeries, including bilateral salpingo-oophorectomies and/or total abdominal hysterectomy. The timing and safety of combining these procedures with autologous breast reconstruction (ABR) are debated. This study assesses the impact of concurrent ABR and gynecologic surgeries on clinical and patient-reported outcomes.

View Article and Find Full Text PDF

Background: Individuals with Down syndrome (DS), the genetic condition caused by trisomy 21 (T21), display clear signs of immune dysregulation, including high rates of autoimmunity and severe complications from infections. Although it is well established that T21 causes increased interferon responses and JAK/STAT signaling, elevated autoantibodies, global immune remodeling, and hypercytokinemia, the interplay between these processes, the clinical manifestations of DS, and potential therapeutic interventions remain ill defined.

Methods: We report a comprehensive analysis of immune dysregulation at the clinical, cellular, and molecular level in hundreds of individuals with DS, including autoantibody profiling, cytokine analysis, and deep immune mapping.

View Article and Find Full Text PDF

Immunochemotherapy plus radiotherapy versus immunochemotherapy alone as first-line treatment for treatment-naïve, advanced esophageal squamous cell carcinoma (AEC-ICR-1st): A multi-center cohort study.

Cancer Lett

December 2024

Department of Radiation Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, 300060, China. Electronic address:

Immunochemotherapy is Currently the standard first-line treatment for advanced esophageal squamous cell carcinoma (ESCC). However, its prognosis remains unsatisfactory. We aimed to evaluate the efficacy and safety of immunochemotherapy plus radiotherapy (ICR) compared with immunochemotherapy (IC) alone as a first-line treatment for advanced ESCC.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!